glp-1 drugs alzheimer's 🧐Will GLP-1RA be the future of altzeimers treatement? 🧠There are multiple studies underway assessing the effectiveness of class of medications in prevention and/or delay of dementia 🧠Alzheimer's makes up 60%-80% Could diabetes and weight loss

Latin America held a 3% share of the market in 2025 and is expected to grow at a significant CAGR of 14% during the projection period, driven by GLP-1 medications that are driving structural health and economic shifts across Latin America by curbing surging obesity and type-2 diabetes rates, spurring vast biopharma investments, and fundamentally changing consumer habits in the fast-moving consumer goods sector

Dosing should always start low and increase gradually

& Koya, D

New Year, New Bod

The study in Nature Medicine did not report on eye diseases, however, says Aleksandra Rachitskaya, MD, a vitreoretinal surgeon at the Cole Eye Institute

Often yes for the program subscription, to show it treats a diagnosed condition